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Protein restriction (PR) is important for the benefits of
dietary restriction on longevity and stress resistance,
but relevant nutrient sensors and downstream effec-
tors in mammals remain poorly defined. We used
PR-mediated protection from hepatic ischemia re-
perfusion injury to probe genetic requirements for
the evolutionarily conserved nutrient sensors GCN2
and mTORC1 in stress resistance. One week of PR
reduced free amino acids and circulating growth fac-
tors, activating GCN2 and mTORC1 repressor tuber-
ous sclerosis complex (TSC). However, although
GCN2 was dispensable for PR-induced protection,
hepatic TSC1 was required. PR improved hepatic in-
sulin sensitivity in a TSC1-dependent manner prior to
ischemia, facilitating increased prosurvival signaling
and reduced apoptosis after reperfusion. These
benefits were partially abrogated by pharmacolog-
ical PI3K inhibition or genetic deletion of the insulin
receptor in hepatocytes. In conclusion, improved
insulin sensitivity upon short-term PR required
TSC1, facilitated increased prosurvival signaling af-
ter injury, and contributed partially to PR-mediated
resistance to clinically relevant ischemia reperfusion
injury.INTRODUCTION
Dietary restriction (DR) is loosely defined as reduced food intake
without malnutrition and refers to a variety of dietary interven-
tions including both simple reduction of calorie intake and re-
striction of specific macronutrients. Beneficial health effects of
DR were reported in the 1930s, when DR was shown to extend
longevity in rats (McCay et al., 1935). DR has since been shown
to increase maximal and average lifespan in multiple species
including yeast, worms, flies, fish, and rodents (Fontana et al.,
2010). In addition to the metabolic and cardiovascular improve-
ments seen in mammals, DR also improves resistance to a vari-
ety of stressors such as chemotherapeutic agents (Cheng et al.,1160 Cell Reports 8, 1160–1170, August 21, 2014 ª2014 The Author2014; Raffaghello et al., 2008) and ischemia reperfusion injury
(IRI) to the kidney, liver, heart, and brain (Mitchell et al., 2010;
Robertson and Mitchell, 2013; Varendi et al., 2014).
Restriction of calories from any macronutrient source—pro-
teins, lipids, or carbohydrates—can result in DR benefits,
including lifespan extension. Therefore, the term DR has been
used interchangeably with caloric restriction. However, accumu-
lating evidence suggests that specific macronutrients—namely,
amino acids—play a role in DR benefits beyond their caloric
value (Levine et al., 2014; Piper et al., 2011; Solon-Biet et al.,
2014). Numerous studies in rodents have shown that total pro-
tein restriction and restriction of the individual essential amino
acids (EAAs) tryptophan and methionine increase longevity in
rats and mice (Gallinetti et al., 2013). In addition to longevity
extension, dietary protein or individual EAA restriction can both
mediate other DR-like effects, including improved insulin sensi-
tivity upon leucine restriction (Xiao et al., 2011) and protection
against IRI in liver and kidney upon tryptophan restriction
(Peng et al., 2012). While EAA, protein, and total calorie restric-
tion induce shared phenotypes, including decreased adiposity,
decreased circulating growth hormones (insulin, IGF-1), and
improved insulin sensitivity, whether or not these are common
effectors of associated benefits remains to be tested.
Two evolutionarily conserved signal transduction pathways
sense amino acids: general control nonderepressible 2 (GCN2)
and mechanistic target of rapamycin complex 1 (mTORC1).
GCN2 senses the absence of any individual amino acid via bind-
ing to uncharged cognate tRNAs and activates the amino acid
starvation response by phosphorylating Ser51 of the translation
initiation factor eIF2a. This results in global translational sup-
pression together with translational derepression of specific
mRNAs such as Atf4 (Gallinetti et al., 2013). GCN2 is required
for mediating the beneficial effects of short-term individual EAA
deficiency against hepatic and renal IRI (Peng et al., 2012).
mTORC1 is a complex of the serine/threonine kinase mTOR,
Raptor, and mLST8 as core essential components and inte-
grates various growth stimulating signals including amino acids,
energy, and growth factors (Dibble andManning, 2013). Intracel-
lular amino acids, and in particular the branched-chain amino
acid leucine, are sensed by mTORC1 via an upstream mecha-
nism involving the Rag GTPases (Sancak et al., 2008) and a
regulatory complex referred to as the Ragulator (Efeyan et al.,
2012). Leucine sufficiency allows recruitment of mTORC1 tos
the lysosomal surface via the Ragulator. There, mTORC1 can be
activated by the small GTPase Rheb, which in turn is negatively
regulated by the GTPase-activating protein (GAP) tuberous scle-
rosis complex 2 (TSC2), which functions in a complex with TSC1
and TBC1D7 (the TSC complex) (Dibble et al., 2012; Huang and
Manning, 2008). The TSC complex is a critical negative regulator
of mTORC1 that integrates signals from energy levels and
growth and endocrine factors, such as insulin. Although growth
factor-based TSC-dependent inhibition of mTORC1 is experi-
mentally separable from amino acid-based Ragulator-depen-
dent inhibition in vitro (Menon et al., 2014), whether the TSC
complex plays a role in controlling mTORC1 in response to die-
tary protein restriction in vivo remains unknown.
Inhibition of mTORC1 (Harrison et al., 2009; Lamming et al.,
2012; Miller et al., 2011, 2014; Wu et al., 2013) or its direct target,
S6K (Selman et al., 2009), has been implicated in DR-like bene-
fits including lifespan and healthspan extension; however,
the requirement for mTORC1 inhibition in DR-mediated stress
resistance, and the potential role of the TSC complex, remain un-
known. Although S. cerevisiae and C. elegans lack TSC homo-
logs, overexpression of TSC1 and TSC2 in Drosophila extends
longevity, consistent with a beneficial role of reduced mTORC1
signaling (Kapahi et al., 2004). A protective role of the TSC com-
plex via autophagy induction in an mTORC1-dependent manner
has also been suggested in a recent study of neuroprotection
against ischemia (Papadakis et al., 2013).
IRI is a multifactorial acute stress involving occlusion of blood
flow to an organ or tissue for a certain period of time (ischemia)
and subsequent return of blood flow (reperfusion). During the
ischemic period, cells are deprived of oxygen and nutrients,
resulting in ATP depletion, loss of membrane potential, and
accumulation of toxic byproducts. Subsequent reperfusion in-
troduces additional damage via the actions of inflammatory
mediators, leading to both apoptotic and necrotic cell death
(Jaeschke, 2003). IRI underlies a variety of clinically significant
events ranging from heart attack and stroke to surgical interven-
tions requiring temporary restriction of blood flow. Here, we
investigated the contributions of the TSC/mTORC1 and GCN2
pathways in sensing dietary protein restriction and mediating
protective effects against hepatic IRI using mice deficient in
GCN2 or lacking hepatocyte-specific expression of the essential
TSC complex component TSC1.
RESULTS
Dietary Protein Restriction Mediates Stress Resistance
Independent of GCN2
To determine an optimal 1-week dietary preconditioning regimen
against hepatic IRI, we focused on restricting dietary protein
intake either by restricting intake of a complete diet (35% or
55% restriction) or by removing protein from the diet (protein re-
striction [PR]) (Figure S1A). Food restriction was calculated on
the basis of food intake of ad libitum-fed mice on a complete
diet and normalized by animal weight (Figure S1B). Because
mice on a protein-free diet often display temporary aversion to
food intake (Peng et al., 2012), the PR diet was restricted by
35% to normalize daily food intake between experiments. He-
patic IRI was induced by clamping the hepatic artery, portalCelvein, and the bile duct for 30–35 min, followed by reperfusion
for up to 24 hr. Liver damage was assessed by measuring the
release of cellular enzymes into the bloodstream. Maximal pro-
tection correlated with the least protein intake rather than restric-
tion of calories (Figure 1A). Therefore, we used the PR regimen to
further characterize the responsible signaling pathways and
downstream effector mechanisms.
Recently, we showed that GCN2 is required for mediating the
protective effects of single-EAA-restricted diets against renal
and hepatic IRI (Peng et al., 2012). To test whether GCN2
is required for mediating the benefits of total protein restric-
tion against hepatic IRI, we preconditioned Gcn2 knockout
(GCN2KO) mice on complete, tryptophan-restricted (Trp), or
PR diets for 1 week. Damage assessment 3 hr after reperfusion
revealed no significant difference between complete and Trp
diets; however, GCN2KO mice preconditioned on the PR
regimen were significantly protected (Figures 1B and S1C).
Thus, GCN2 was dispensable for preconditioning by PR, indi-
cating the likely involvement of another amino acid-sensing
pathway.
The mTORC1 pathway can also sense amino acids, and it is
inhibited in the absence of specific amino acids, including
leucine. We thus tested whether the mTORC1 pathway is still
responsive to amino acid deprivation in vitro in two different
GCN2KO cell types: primary dermal fibroblasts and primary he-
patocytes (Figure 1C). Phosphorylation of downstream targets of
mTORC1, including S6K1, its target S6, and 4E-BP1 (as scored
by mobility shifting), were proportionately reduced in both wild-
type (WT) and GCN2KO cells upon total amino acid withdrawal.
We conclude that the mTORC1 pathway can sense amino acid
restriction independent of GCN2 and could thus be a potential
mediator of PR preconditioning effects.
The TSC Complex Is Required for Inhibition of mTORC1
upon PR In Vivo
We next determined the effects of PR on hepatic mTORC1 activ-
ity in vivo using both WT and liver-specific Tsc1 knockout
(LTsc1KO) mice, a model of constitutive mTORC1 activation in
the liver (Kenerson et al., 2011; Menon et al., 2012; Sengupta
et al., 2010; Yecies et al., 2011). WT and LTsc1KO mice were
fed a complete or PR diet for 1 week (Figure S2A). Both geno-
types lost approximately 20% of their body weight (Figures 2A
and S2B), including loss of adipose mass (Figure S2C). In WT
mice on PR, livers tended to weigh less and were thus main-
tained as a percentage of body weight; in LTsc1KO mice on
PR, liver weights did not decrease, resulting in disproportion-
ately larger livers (Figure 2A), consistent with failure of LTsc1KO
mice to reduce mTORC1 signaling upon PR.
To confirm differential regulation of hepatic mTORC1 signaling
upon PR, we looked in liver extracts at downstream mTORC1
targets and related nutrient/energy-sensing pathways. PR
increased phosphorylation of eIF2a (Figures 2B and S2D) and
expression of downstream markers of the GCN2-dependent
amino acid starvation response, including the ATF4 target
gene Asns (Figure S2E). Higher baseline eIF2a phosphorylation
in LTsc1KOs could be due in part to higher endoplasmic reticu-
lum (ER) stress (Menon et al., 2012). In WT livers, we observed a
reduction in S6K and S6 phosphorylation upon PR (Figures 2Bl Reports 8, 1160–1170, August 21, 2014 ª2014 The Authors 1161
Figure 1. Dietary Protein Restriction Medi-
ates Stress Resistance Independent of
GCN2
(A) Serum LDH, ALT, and AST activity before
ischemia (0 hr) and 3 hr after reperfusion in male
mice preconditioned on the indicated diets for
1 week prior to hepatic IRI; n = 5 mice/group.
Complete: ad libitum access to a complete diet;
35% DR: 65% of ad libitum food allowance on a
complete diet; 55% DR: 45% of ad libitum food
allowance on a complete diet, PR: 65% of ad li-
bitum food allowance on a protein-free diet. As-
terisks indicate the significance of the difference
versus the complete group by one-way ANOVA
with Dunnett’s test for multiple comparisons;
multiplicity adjusted p values; *p < 0.05, **p <
0.005, ***p < 0.0005, ****p < 0.0001.
(B) Serum ALT activity before ischemia (0 hr) and
3 hr after reperfusion in female GCN2KO mice
preconditioned on the indicated diets for 1 week
prior to hepatic IRI; n = 4–5mice/group. Complete:
ad libitum access to a complete diet; PR: 65% of
ad libitum food allowance on a protein-free diet;
Trp: 65% of ad libitum food allowance on a
tryptophan-free diet. Asterisk indicates the sig-
nificance of the difference versus the complete
group by Student’s t test; *p < 0.05.
(C) Immunoblots of markers of mTORC1 signaling
in extracts from primary dermal fibroblasts or he-
patocytes isolated from WT or GCN2KO mice and
treated with the indicatedmedia in the presence of
10% dialyzed FBS (2 hr for mouse dermal fibro-
blasts, 3 hr for hepatocytes). Complete: complete
DMEM; AA-free: amino acid-free DMEM; MEM:
minimum essential medium amino acidmix; AA: all
amino acids added back to 13 DMEM concen-
tration; Rapamycin, 20 nM.
Data in all panels are shown as means ± SD. See
also Figure S1.and S2D). Total levels of 4E-BP1, which is also an ATF4 target
gene (Yamaguchi et al., 2008), increased in both genotypes
upon PR; therefore, changes in phosphorylation of this mTORC1
target are difficult to interpret (Figures 2B and S2E). mTORC1
signaling in Tsc1KO livers was greatly increased relative to WT
and unaffected by PR, if not slightly elevated (Figures 2B and
S2D). Interestingly, AMPK phosphorylation in some WT livers
was increased upon PR, although the observed changes were
not statistically significant likely due to biological variability; there
was no evidence of increased AMPKphosphorylation upon PR in
LTsc1KO livers (Figures 2B and S2D).
Differential Reduction of Essential Amino Acids and
Growth Factors In Vivo upon PR
To test the role of amino acid deficiency on cell-autonomous
mTORC1 signaling, primary WT or Tsc1KO hepatocytes were
cultured for 2 hr in media lacking amino acids. In WT hepato-
cytes, this led to the reduction of S6K and S6 phosphorylation
below the level of detection (Figure 3A). Although Tsc1KO hepa-
tocytes had much higher baseline levels of p-S6K, they also re-
sponded to amino acid deprivation in vitro, confirming the ability
of amino acid deprivation to reduce mTORC1 activity indepen-
dent of the TSC complex.1162 Cell Reports 8, 1160–1170, August 21, 2014 ª2014 The AuthorIf amino acid deficiency could at least partially abrogate
mTORC1 signaling in Tsc1KO hepatocytes in vitro, why did PR
fail to reduce mTORC1 signaling at all in LTsc1KO livers in vivo?
To answer this, we first measured free amino acids in the serum
and in liver. One week of PR reduced most free EAAs, in the
serum and liver in both WT and LTsc1KO animals, but only by
approximately 20%–30% on average (Figures 3B and 3C);
nonessential amino acids were not uniformly affected (Figures
S3A and S3B). Blood glucose was similarly reduced upon PR
in both genotypes by 20%–40% (Figure 3D). However, circu-
lating levels of growth factors were reduced by more than
5-fold for insulin and 3-fold for IGF-1 upon PR (Figures 3E
and 3F). Taken together, these data suggest that buffering of
free amino acid concentrations in vivo upon PR prevents Rag/
Ragulator-based mTORC1 inhibition in LTsc1KO livers and
confirms LTsc1KO mice as a suitable model of constitutive he-
patic mTORC1 activation, despite intact systemic changes in
upstream mTORC1 regulators in response to diet.
The TSC Complex Is Required for Benefits of PR against
Acute Hepatic Stress
To determine the requirement for the TSC complex and suppres-
sion of mTORC1 on PR-mediated stress resistance, we testeds
Figure 2. The TSC Complex Is Required for Inhibition of mTORC1 upon PR In Vivo
(A) Body and liver weights of the indicated genotype after 1 week on the indicated diet; n = 4–5 mice/group. Body weight on the last day of treatment is rep-
resented as percentage of initial weight (top). Liver weights on the last day of treatment are represented as absolute values (middle) and percentages of body
weight (bottom). Asterisks indicate the significance of the difference between diets within genotype by Student’s t test; **p < 0.01, ***p < 0.00001.
(B) Immunoblots of markers of mTORC1, GCN2, and AMPK activation in liver extracts from WT and LTsc1KO male mice after 1 week on the indicated diet.
Data in all panels are shown as means ± SD. See also Figure S2.the response of female WT and LTsc1KO mice to hepatic IRI.
We observed a significant reduction of the serum damage
markers lactate dehydrogenase (LDH), alanine transaminase
(ALT), and aspartate transaminase (AST) in WT animals on PR,
but this benefit was lost in LTsc1KOs (Figures 4A and S4A). As
a control, changes in the serum levels of these enzymes were
not due to differential enzyme activity levels in undamaged livers
(Figure S4B). Hematoxylin and eosin (H&E)-stained sections
from formalin-fixed livers harvested 24 hr after reperfusion
from all four groups were analyzed for necrotic cell death,
which appeared as lightly stained areas with loss of hepatocyte
morphology (Figure 4B). Blind scoring in serial sections con-
firmed the reduction of necrotic tissue in WT livers upon PR
and the loss of this benefit in LTsc1KOs (Figure 4C). The same
relative differences in hemorrhagic necrosis could also be
observed at the macroscopic level in whole livers (Figure 4B).
Body temperatures of LTsc1KO and WT mice upon PR were
similarly reduced (Figure S4C), ruling out the possibility of differ-
ential temperatures in protection by PR in WT mice. Finally, PR-
mediated protection from hepatic IRI was partially abrogated in
LTsc1KOmales (Figure S4D). Taken together, these results indi-
cate the requirement for the TSC complex in the protective effect
of PR against hepatic IRI.
In order to investigate potential differences in protective
mechanisms by total protein (PR) and tryptophan restriction
(Trp–), we tested the response of female LTsc1KO mice to
1 week of preconditioning on a Trp diet. Interestingly, we
observed that LTsc1KO mice were still responsive to the Trp
diet in terms of protection from hepatic IRI (Figure S4E). Taken
together, these data indicate that beneficial effects of total pro-
tein restriction and tryptophan restriction have different geneticCelrequirements, suggesting a parallel rather than epistatic relation-
ship between TSC/mTORC1 and GCN2 amino acid-sensing
pathways in protection from hepatic IRI.
Rapamycin is a partial mTORC1 inhibitor that increases
longevity in mice (Harrison et al., 2009; Miller et al., 2011,
2014). We tested the ability of rapamycin to induce benefits
against hepatic IRI similar to PR. To this end, WT mice were
injected with rapamycin at varying concentrations for up to
1 week in the absence of any dietary intervention. Despite
reducing mTORC1 activity, none of the rapamycin regimens
tested were beneficial against hepatic IRI (Figures S4F and
S4G). Interestingly, we observed that thrice-weekly rapamycin
treatment partially abrogated PR benefits and reducedmTORC2
activity as assessed by NDRG1 phosphorylation (Figures S4G
and S4H), suggesting that the effects of rapamycin on mTORC2
might be detrimental in the context of hepatic IRI.
The TSC Complex Is Required for Improved Hepatic
Insulin Sensitivity upon PR
By what downstream mechanism does TSC complex activation
and mTORC1 repression improve stress resistance? Improved
insulin sensitivity upon DR is associated with a wide range of
health benefits, including stress resistance and extended
longevity (Fontana et al., 2010). We thus tested the ability of
PR to increase hepatic insulin sensitivity in a TSC1-dependent
manner. One week of PR reduced fasting insulin, resulting in a
significantly reduced HOMA-IR (Figures S5A–S5C), consistent
with improved insulin sensitivity. To directly test the effects of
PR on hepatic insulin sensitivity, we measured the levels of Akt
phosphorylation in extracts from WT livers following stimulation
with insulin. WT mice on PR for 1 week had higher levels ofl Reports 8, 1160–1170, August 21, 2014 ª2014 The Authors 1163
Figure 3. Differential Reduction of Essential Amino Acids and Growth Factors In Vivo upon PR
(A) Immunoblots of mTORC1 targets from extracts of primary hepatocytes isolated fromWT or LTsc1KOmice and starved of amino acids in the presence of 10%
dialyzed serum (dFBS) for 2 hr prior to lysis, coincident with 13 MEM addition ±20 nM rapamycin (Rap) as indicated.
(B and C) Free EAA levels in serum (B) and liver (C) of WT or LTsc1KOmice on the indicated diet expressed as fold change relative to theWT complete diet group;
n = 4–5 mice/group. Asterisks/number signs indicate the significance of the difference between diets within genotype by Student’s t test; */#p < 0.05.
(D–F) Blood glucose, serum insulin (E) and IGF-1 (F) levels ofWT or LTsc1KOmice on the indicated diet; n = 4–5mice/group for each experiment, with data pooled
from three separate experiments (D). Asterisks indicate the significance of the difference between diets within genotype by Student’s t test; *p < 0.05, **p < 0.01,
****p < 0.0000001.
Data in all panels are shown as means ± SD. See also Figure S3.pAkt-S473 and pAkt-Thr308 compared to controls (Figure S5D).
Levels of Akt phosphorylation in Tsc1KO livers upon insulin stim-
ulation were lower than in WT livers, consistent with previous
findings (Yecies et al., 2011), but did not improve upon PR in
Tsc1KOs as they did in WT controls (Figure 5A). Together, these
findings show that the TSC complex is required for improvement
in hepatic insulin sensitivity upon PR.
In the context of DR, improved insulin sensitivity is associated
with reduced anabolic hormone levels (as observed here; Fig-
ures 3E and 3F) and, consequently, reduced insulin/IGF-1
signaling. Reduced insulin/IGF-1 signaling is an evolutionarily
conserved mechanism regulating longevity and stress resis-
tance in part by controlling cytoprotective gene expression (Fon-
tana et al., 2010). To evaluate a potential impact of increased
cytoprotective gene expression, we measured expression of
genes controlled by both FOXO and NRF2 transcription factors.
However, no significant increases in the levels of these genes
were observed upon PR, nor did TSC1 ablation have consistent
effects (Figures S5E and S5F).
In contrast to the potential benefits of reduced insulin/IGF-1
signaling named above, increased growth factor signaling after
injury can trigger antiapoptotic survival signaling and improve
functional recovery (Fuglesteg et al., 2009; Jonassen et al.,
2001; Liu et al., 2007). In order to address the potential protective
effects of increased insulin/IGF-1 signaling after injury in the
context of protection from hepatic IRI, we determined the status
of insulin/Akt signaling at various time points during ischemia
and after reperfusion. Akt signaling was dramatically reduced
during ischemia and returned rapidly within 15min of reperfusion1164 Cell Reports 8, 1160–1170, August 21, 2014 ª2014 The Author(Figure S5G). We next looked at insulin/Akt signaling in the
context of PR. During ischemia, Akt signaling was maintained
at higher levels in PR mice (Figure S5H). Although no consistent
differences were detected between PR and control mice 30 min
after reperfusion (Figure S5H), phosphorylation of the Akt target
FOXO1was clearly increased 3 hr after reperfusion in livers of PR
versus complete diet groups (Figure 5B). Importantly, this in-
crease in FOXO1 phosphorylation was absent in LTsc1KO livers
(Figure 5B).
To explain this boost in insulin/Akt signaling 3 hr after reperfu-
sion specifically inWTmice preconditioned on PR, wemeasured
serum insulin at multiple time points during the procedure. In WT
mice, serum insulin levels fell dramatically below preoperative
levels during the ischemic period independent of diet and
increased gradually following reperfusion (Figure 5C). Impor-
tantly, the recovery of circulating insulin was significantly higher
3 hr after reperfusion in PR animals than in control mice. This in-
crease in insulin was unlikely to be secondary to an increase in
blood glucose, since glucose levels remained significantly lower
than initial levels 3 hr after reperfusion (Figure 5D). As a result of
the differential insulin sensitivity between WT and LTsc1KO
mice, only WT mice displayed the boost in Akt activity upon
PR (Figure 5B).
Increased Prosurvival Signaling and Reduced Apoptosis
Contribute to PR-Mediated Protection
FOXO1 regulates apoptosis via transcription of proapoptotic
Bcl-2 family members including Bim, Puma, and Bnip3 (Zhang
et al., 2011). Although hepatic IRI is largely driven by necrotics
Figure 4. The TSC Complex Is Required for
Benefits of PR against Acute Hepatic Stress
(A) Serum LDH, ALT, and AST activity before
ischemia (0 hr) and 3 or 24 hr after reperfusion in
female WT or LTsc1KO mice preconditioned on
the indicated diets for 1 week prior to hepatic IRI;
n = 4–6 mice/group for each experiment, with
data pooled from four separate experiments
for 0 and 3 hr and a single experiment for 24 hr.
Asterisks indicate the significance of the
difference between diets within genotype by
Student’s t test; **p < 0.001, ***p < 0.00001,
****p < 1 3 108.
(B) Representative images of H&E-stained sec-
tions from nonischemic (left) or ischemic livers
24 hr after reperfusion (right) from WT or
LTsc1KO mice preconditioned on the indi-
cated diets for 1 week prior to hepatic IRI.
Lightly stained areas with loss of hepatocyte
morphology indicate necrotic tissue. Right:
representative images of whole livers 24 hr after
IRI and fixed with formalin, with areas of hem-
orrhagic necrosis appearing as dark red. Scale
bar, 400 mm.
(C) Quantification of hepatic cell death expressed as percentages of necrotic region/field in three to five mice/group, three sections/sample. Asterisks indicate
the significance of the difference between diets within genotype by Student’s t test; **p < 0.01; ns, not significant.
Data in all panels are shown as means ± SD. See also Figure S4.cell death, inhibition of apoptosis protects from injury (Datta
et al., 2013). We examined protein levels of proapoptotic Bcl-2
family members Bik, Bak, PUMA, BID, and Bad in WT and
LTsc1KO animals on PR or control diets for 1 week. In WT livers,
Bik and BID were reduced upon PR, consistent with a decrease
in the proapoptotic environment (Figure 6A). In LTsc1KO livers,
on the other hand, proapoptotic Bcl-2 family members were
generally expressed at higher levels than in WT livers and were
not reduced upon PR (Bik, Bak, and Bad; Figure 6A). Phosphor-
ylation of Bad at Ser112 and Ser136 can inhibit its binding to Bcl-
2 and Bcl-xL and thus reduce its proapoptotic activity (Danial,
2008). Phosphorylation of Bad at Ser112 was decreased upon
PR in LTsc1KOs, unlikeWTs (Figure 6A). Three hours after reper-
fusion, total Bad levels were reduced in WTs upon PR but re-
mained the same in LTsc1KOs with reduced phosphorylation
(Figure 6B).
To determine if the observed increase in insulin/Akt signaling
and decrease in proapoptotic factors resulted in reduced
apoptosis in WT livers upon PR, sections from livers harvested
3 hr postreperfusion were analyzed by TUNEL staining. As ex-
pected, WT livers preconditioned with PR had significantly fewer
TUNEL-positive cells compared to controls, and this protective
effect of diet was absent in LTsc1KO livers (Figures 6C and 6D).
In order to directly test the role of differential postreperfusion
insulin signaling in PR-mediated hepatic IRI protection, we
tested the effects of the PI3K inhibitor wortmannin (Ren et al.,
2011). Treatment 1 hr prior to induction of ischemia increased
blood glucose (Figure S6A), reduced in vivo Akt phosphorylation
(Figure 6E), and partially abrogated PR-mediated benefits
against hepatic IRI (Figures 6F and S6B). Because of the rela-
tively short half-life of wortmannin in vivo, hepatic Akt/FOXO
signaling was restored by 3 hr after reperfusion (Figure S6C),
which may explain the partial effect. Finally, we tested theCelresponse of liver-specific insulin receptor knockout (LIrKO)
mice (Michael et al., 2000) to PR-mediated hepatic IRI precondi-
tioning. LIrKO mice had lower levels of Akt phosphorylation in
ischemic liver lobes at 3 hr postreperfusion (Figure 6G), and
their response to PR was worse than WT mice on PR (Figures
6H and S6D).
A model for the collective action of PR on increased insulin
sensitivity and relative insulin levels in WT animals after ischemia
and reperfusion, resulting in increasing prosurvival signaling and
reduced cell death, is presented in Figure 7. These latter effects
were dependent on the expression of TSC1 in hepatocytes and
were partially blocked by genetic and pharmacological inhibition
of insulin/Akt signaling.
DISCUSSION
Previously, we reported a genetic requirement for Gcn2 in medi-
ating surgical stress resistance upon single-EAA restriction
(Peng et al., 2012). Here, we found that GCN2 was no longer
required when total protein was removed from the diet, suggest-
ing involvement of a redundant nutrient-sensing pathway. We
thus tested the role of themTORC1 pathway usingmice deficient
in Tsc1 with constitutive mTORC1 activation specifically in the
liver. The role of the mammalian TSC complex in DR benefits
has not been previously tested. Here, we found that two major
benefits of PR, namely improved hepatic insulin sensitivity and
stress resistance, both required the TSC complex.
Consistent with intact Ragulator-based mechanisms of
mTORC1 inhibition in vitro, TSC1KO hepatocytes had higher
baseline levels of mTORC1 activity but were still responsive to
amino acid deprivation. Nonetheless, hepatic mTORC1 activity
in vivo was completely recalcitrant to total dietary protein restric-
tion in LTsc1KO versus WT livers, despite reduced serum andl Reports 8, 1160–1170, August 21, 2014 ª2014 The Authors 1165
Figure 5. The TSC Complex Is Required for
ImprovedHepatic InsulinSensitivityuponPR
(A) Insulin sensitivity as determined by immuno-
blotting for markers of Akt pathway activation in
liver extracts from mice fasted for 6 hr and then
stimulated with 0.5 U/kg insulin by portal vein
injection 3 min before harvest.
(B) Akt activation status as determined by immu-
noblotting of liver extracts 3 hr after reperfusion
from mice preconditioned for 1 week on the indi-
cated diet prior to induction of hepatic IRI.
(C) Serum insulin levels from tail blood of WT mice
preconditioned for 1 week on the indicated diet
taken prior to ischemia (0 hr, n = 4), at the end of the
ischemic period (30 min I, n = 3–4), 30 min after the
reperfusion period (30 min R, n = 3), or 3 hr after
reperfusion (3hrR,n=11–12). Asterisk indicates the
significance of the indicated comparison according
to a Kruskal-Wallis test followed by Dunn’s multiple
comparisons test; *p < 0.05; ns, not significant.
(D) Blood glucose levels of mice on the indicated
diets for 1weekbefore hepatic IRI,measuredbefore
(0 hr) and 3 hr after reperfusion; n = 8–10 mice/
group. Asterisks indicate the significance of the
difference between 0 and 3 hr values by Student’s
t testwithin thediet group; **p<0.001, ***p<0.0001.
Data in all panels are shown as means ± SD. See
also Figure S5.liver free amino acids and activation of the GCN2-dependent
amino acid starvation response in both genotypes. Our inter-
pretation of these data is that the concentration of leucine or
other critical amino acids required to trigger Ragulator-based
mTORC1 inhibition can be achieved by removal of free amino
acids in vitro but cannot be achieved in vivo due to the buffering
capacity on the organismal level against drastic changes in
steady-state levels of free amino acids. What level of free amino
acids are required to activate Ragulator in hepatocytes in vivo,
and whether longer periods of dietary protein deprivation or
combined protein and calorie deprivation such as fasting ever
result in a drop below these levels, remain to be determined.
While female LTsc1KO mice almost entirely lost the precondi-
tioning benefit of PR against hepatic IRI, parallel experiments in
males showed that despite similar functional protection by PR as
in females, this protection was only partially lost in LTsc1KO
males. Although the reason for this apparent sex-based differ-
ence in the genetic requirement for Tsc1 is unclear, we note
that the lifespan extension benefits of ablation of the down-
stream mTORC1 target S6K and mTOR+/mLST8+/ models
are also preferentially observed in females (Lamming et al.,
2012; Selman et al., 2009).
In addition to total protein restriction, we also tested the
effects of tryptophan restriction on LTsc1KO mice. Interestingly,
LTsc1KO mice exhibited a response comparable to WT mice.
Together with the previous findings indicating a requirement
for the amino acid deprivation sensor GCN2 in protection af-
forded by tryptophan restriction (Peng et al., 2012), these results
suggest that GCN2 and mTORC1 may act in parallel pathways,
eventually converging on the same beneficial outcome. Whether
or not this occurs through a common downstream mechanism
remains to be determined. However, the lack of improvement1166 Cell Reports 8, 1160–1170, August 21, 2014 ª2014 The Authorof insulin sensitivity in GCN2KO mice in response to leucine
restriction (Xiao et al., 2011) is consistent with the possibility of
improved hepatic insulin sensitivity as a potential point of
convergence.
Inhibition of TOR signaling has been implicated in longevity,
metabolism, and stress resistance, including the response to
DR in lower organisms, but its downstream effector mechanisms
in mammals are not well established (Kaeberlein, 2013; Kaeber-
lein et al., 2005; Zid et al., 2009). Improved insulin sensitivity is a
metabolic hallmark of multiple different DR regimens, including
PR (Fontana et al., 2010; Toyoshima et al., 2010), and is poten-
tially controlled in part by mTORC1-based feedback inhibition
of IRS-1 (Howell and Manning, 2011). Here, we found that
improved hepatic insulin sensitivity upon PR required the TSC
complex. Interestingly, PR appeared to reduce hepatic insulin
sensitivity in LTsc1KOs, although the reason for this remains
unclear.
The fact that both increased and decreased signaling through
the evolutionarily conserved insulin/IGF-1 pathway can improve
cellular stress resistance and organismal survival is paradoxical
(Rincon et al., 2004; Tang, 2006). Reduced insulin signaling, due
to reduced insulin levels as with DR or in constitutive genetic
models of reduced insulin/IGF-1 signaling, can extend longevity
and increase stress resistance in part through activation of cyto-
protective gene expression normally inhibited by insulin/Akt
signaling. For example, in C. elegans, activation of FoxO/Daf-
16 targets involved in stress resistance has been implicated in
DR-mediated longevity (Greer et al., 2009). On the other hand,
increased insulin action is desirable under certain circum-
stances, for example to promote cell survival after an ischemic
insult. Consistent with this, increased insulin/PI3K/Akt signaling
has been shown to play a protective role in both the rat isolateds
Figure 6. Increased Prosurvival Signaling and Reduced Apoptosis Contribute to PR-Mediated Protection
(A and B) Immunoblots of proapoptotic Bcl-2 family members in liver extracts from WT or LTsc1KO mice preconditioned on the indicated diets for 1 week and
harvested without ischemia (A) or 3 hr after reperfusion (B). NI, nonischemic.
(C and D) TUNEL staining of nonischemic or ischemic livers from the indicated diet-genotype combinations 3 hr after reperfusion. (C) Quantification was
performed by blind scoring of the number of TUNEL+ nuclei per 2003 field in ten random fields from each sample, with n = 5 mice/group. Asterisks indicate the
significance of the difference between diets within genotype by Student’s t test; *p < 0.05. (D) Representative images of TUNEL-stained sections. Scale bar,
100 mm.
(E) Immunoblot of Akt phosphorylation in liver extracts from WT mice injected with vehicle or 1 mg/kg wortmannin 1 hr prior to harvest.
(F) SerumALT and AST activity 3 hr after reperfusion inWTmice preconditioned on the indicated diets for 1 week and injected with vehicle or 1mg/kg wortmannin
(Wmn) 1 hr prior to hepatic IRI; n = 8–10 mice/group. Statistical significance was assessed by Student’s t test between complete-V and PR-V groups
(***p < 0.0005) or between PR-V and PR-Wmn groups (#p < 0.05).
(G) Immunoblot of liver extracts from WT mice on complete diet, or WT and LIrKO mice preconditioned with PR for 1 week and harvested 3 hr after reperfusion.
(H) Serum LDH and AST activity before ischemia (0 hr) and 3 hr after reperfusion in maleWT and LIrKOmice preconditioned on the indicated diets for 1 week prior
to hepatic IRI; n = 4–5/group. Statistical significance was assessed by Student’s t test between WT-complete and WT-PR groups (***p < 0.0005) or between
WT-PR and LIrKO-PR groups (##p < 0.001).
Data in all panels are shown as means ± SD. See also Figure S6.heart ischemia model (Fuglesteg et al., 2009; Jonassen et al.,
2001; Liu et al., 2007) and other hepatic IRI models (Kamo
et al., 2013) where a protective effect of reduced apoptosis
has been described (Datta et al., 2013).
Our model of improved insulin sensitivity upon PR provides an
answer to this apparent paradox. During the preconditioning
period prior to injury, reduced insulin levels and reduced insu-
lin-dependent mTORC1 activity were required, not to increase
expression of cytoprotective FOXO or NRF2 target genes but
to facilitate improved insulin sensitivity via a decrease in
mTORC1 feedback inhibition. This occurred in WT livers on PRCelbut was prevented in LTsc1KO livers due to constitutive
mTORC1 activation. After injury, increased insulin signaling
led to increased inhibitory FOXO1 phosphorylation, reduced
apoptosis, and improved outcome in insulin-sensitive WT livers.
Inhibition of postreperfusion insulin signaling either pharmaco-
logically, via the PI3K inhibitor wortmannin, or genetically, with
LIrKO mice, partially abrogated PR-mediated protection.
Whether or not IGF-1 plays a role similar to insulin remains to
be tested. Although hepatic IGF-1R expression is low, liver-spe-
cific deletion compromises regeneration (Desbois-Mouthon
et al., 2006); furthermore, IGF-1 can activate the insulin receptorl Reports 8, 1160–1170, August 21, 2014 ª2014 The Authors 1167
Figure 7. Model of TSC/mTORC1 Function and Insulin Sensitivity in
PR-Mediated Hepatic Stress Resistance
Amodel for the effects of dietary protein or tryptophan restriction on improved
hepatic insulin sensitivity prior to an acute ischemic event. After reperfusion,
increased insulin levels and increased hepatic insulin sensitivity facilitate
prosurvival signaling and contribute to protection from injury.directly. Thus, whether with insulin alone or with a combination of
insulin and IGF-1, our model predicts decreased growth factor
signaling prior to injury (resulting in increased insulin/IGF-1
sensitivity) and increased signaling after injury are both required
for maximal protection. It is important to note that because abro-
gation of insulin signaling only partially blocked PR-mediated
protection, additional mechanisms contributing significantly to
protection remain to be identified.
Understanding the mechanistic basis of DR is crucial to the
development of potential interventions that mimic its beneficial
effects. Genetic and pharmacological approaches targeting
nutrient-sensing pathways have yielded similar results to DR in
terms of longevity extension and other beneficial health effects,
suggesting a causal role for the downregulation of these path-
ways in DR benefits (Fontana et al., 2010; Kaeberlein, 2013).
For example, rapamycin extends lifespan in rodents, although
what aspect ofmTORC1 inhibition is responsible remains unclear
(Harrison et al., 2009; Miller et al., 2011, 2014). Despite longevity
extension, rapamycin has negative side effects, including
increased inflammation and reduced insulin sensitivity (Lamming
et al., 2013), and fails to recapitulate many other DR phenotypes
(Miller et al., 2014). In our model, rapamycin not only failed to
recapitulate benefits of PR but also partially abrogated PR bene-
fits, possibly due to its aforementioned negative effects on insulin
signaling via mTORC2 inhibition (Lamming et al., 2013).1168 Cell Reports 8, 1160–1170, August 21, 2014 ª2014 The AuthorHepatic IRI presents a major challenge during various clinical
contexts such as hepatic resection and liver transplantation sur-
geries as well as trauma (Datta et al., 2013; Klune and Tsung,
2010). Ischemic damage to other tissues, including the heart,
brain, and kidney, occurs regularly as an unintended complica-
tion of cardiovascular surgery, leading to significant morbidity
and mortality (Mitchell et al., 2013). Understanding the mecha-
nistic basis of DR-mediated protection could lead to preventa-
tive strategies against these clinically relevant stressors.
EXPERIMENTAL PROCEDURES
Animals and Diets
All animal experiments were performed with the approval of the appropriate
institutional animal care and use committee. WT C57Bl/6J mice were pur-
chased from The Jackson Laboratory at 8–10 weeks of age. LTsc1KO and
GCN2KO mice were backcrossed on the C57Bl/6J background as described
previously (Menon et al., 2012; Peng et al., 2012; Yecies et al., 2011). Irfl/fl mice,
which have been described previously (Michael et al., 2000), were purchased
from The Jackson Laboratory [B6.129S4(FVB)-Insrtm1Khn/J, stock #006955].
Experimental LTsc1KO and littermate control animals were generated by
crossing Tsc1fl/fl (WT) mice with Tsc1fl/fljAlbumin-Cre+/ (LTsc1KO) mice,
GCN2KO and control mice were generated by crossing heterozygotes, and
LIrKO and control mice were generated by crossing Irfl/fl (WT) mice with
Irfl/fljAlbumin-Cre+/ (LIrKO) mice. Animals were kept under standard housing
conditions with ad libitum access to food (Purina 5058) except for the indicated
dietary treatments. Female mice between 10 and 16 weeks of age were used
unless otherwise indicated. LTsc1KO mice were used prior to the age of
16 weeks in order to avoid any potential complications of hepatocellular carci-
nomas, which appear later in life (Menon et al., 2012).
Hepatic Ischemia Reperfusion Injury and Serum Damage Assays
Hepatic IRI was performed by placing a microvascular clamp (Roboz) over
the portal triad for 35 min for female and 30 min for male mice as described
previously (Peng et al., 2012). After surgery, mice were given ad libitum access
to the control diet starting at 3 hr after reperfusion. Serum ALT and AST levels
were measured using Infinity Reagents (Thermo Scientific) and serum LDH
levels using Pointe Scientific reagents with kinetic absorbance assays in a
384-well format with a BioTek Synergy II plate reader and calculated according
to manufacturer’s instructions. For histology, median lobes were formalin
fixed, paraffin embedded, cut into 5 mm sections, and stained with H&E or
TUNEL (Promega). Percentage of necrotic area or TUNEL positivity in each
section was scored blindly.
Primary Dermal Fibroblast and Primary Hepatocyte Isolation
and Treatments
Mouse dermal fibroblasts were isolated from tail skin bymincing into fine slices
followed by overnight collagenase treatment (Invitrogen Collagenase II). Cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 20% fetal
bovine serum (FBS) at 3% oxygen tension. Primary hepatocytes were isolated
via portal vein collagenase treatment (Liberase, Roche) followed by Percoll
gradient centrifugation and cultured in William’s E media with 5% FBS. Amino
acid (AA)-free DMEM was a special formulation of Invitrogen DMEM-12320.
For the amino acid add-back, either MEM amino acid solution (GIBCO)
was used at 13 concentration or individual amino acids were added back to
AA-free medium up to their original concentrations in DMEM and supple-
mented with 10% dialyzed FBS (Invitrogen). Rapamycin was purchased
from Calbiochem.
Serum Measurements and Amino Acid Analysis
Blood glucose was measured with an Easy Step glucometer (Home Aide
Diagnostics). Serum insulin and IGF-1 levels were measured with ELISA assay
kits (Alpco). Serum and liver free amino acid analyses were performed by
mass spectrometry and normalized by volume and total protein content,
respectively.s
Western Blotting
Cells and tissues were homogenized in NP-40 lysis buffer, cleared by centrifu-
gation, separated by SDS-PAGE, and transferred to polyvinylidene fluoride
membranes for blotting. Primary antibodies were purchased from Cell
Signaling Technology except anti-p-BadSer136 and IRb (Santa Cruz Biotech-
nology) and secondary antibodies from Dako.
Statistical Analyses
All data are presented as mean ± SD. Statistical significance was assessed by
Student’s t test for pairwise comparisons or by one-way ANOVA with post hoc
tests as indicated usingMicrosoft Excel or GraphPad Prism. p values less than
0.05 were considered statistically significant. Quantification of western blot
images was performed by ImageJ software.
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